Connection
Elizabeth McFarland to Atazanavir Sulfate
This is a "connection" page, showing publications Elizabeth McFarland has written about Atazanavir Sulfate.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.668 |
|
|
|
-
Smith C, Weinberg A, Forster JE, Levin MJ, Davies J, Pappas J, Kinzie K, Barr E, Paul S, McFarland EJ. Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir. Infect Dis Obstet Gynecol. 2016; 2016:9848041.
Score: 0.522
-
Jao J, Yu W, Patel K, Miller TL, Karalius B, Geffner ME, DiMeglio LA, Mirza A, Chen JS, Silio M, McFarland EJ, Van Dyke RB, Jacobson D. Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study. HIV Med. 2018 03; 19(3):175-183.
Score: 0.146